Davis Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.7K Sell
102
-2
-2% -$181 0.01% 262
2026
Q2
$9.54K Buy
104
+12
+13% +$1.05K 0.01% 268
2026
Q1
$7.84K Buy
92
+3
+3% +$267 0.01% 231
2025
Q4
$7.03K Buy
89
+9
+11% +$706 ﹤0.01% 241
2025
Q3
$6.39K Buy
+80
New +$6.82K ﹤0.01% 245
2025
Q1
$7.5K Hold
80
– – 0.01% 234
2024
Q4
$7.27K Hold
80
– – 0.01% 243
2024
Q3
$8.3K Sell
80
-33
-29% -$3.36K 0.01% 244
2024
Q2
$10.8K Hold
113
– – 0.01% 225
2024
Q1
$10.1K Hold
113
– – 0.01% 216
2023
Q4
$9.01K Buy
+113
New +$8.5K 0.01% 216
2020
Q2
$6K Hold
80
– – 0.01% 200
2020
Q1
$5K Buy
+80
New +$5.64K 0.01% 201

Other funds holding CL

Davis Capital Management's CL Position: Q3 2026 in Review

Davis Capital Management reduced its Colgate-Palmolive (CL) stake by 1.9% in Q3 2026, selling an estimated $181 and leaving 102 shares worth $8.7K. The position accounts for 0.01% of the portfolio, ranked #262.

Davis Capital Management first reported a position in CL in Q1 2020 and has held it in 13 quarters since. The position peaked at $10.8K in Q2 2024. 106 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Davis Capital Management held 102 shares of Colgate-Palmolive worth $8.7K as of Q3 2026.
  • Davis Capital Management sold 2 Colgate-Palmolive shares in Q3 2026, an estimated $181.
  • Colgate-Palmolive made up 0.01% of Davis Capital Management's portfolio in Q3 2026, its #262 holding.
  • Davis Capital Management first reported a position in Colgate-Palmolive in Q1 2020 and has held it in 13 quarters since.
  • Davis Capital Management's Colgate-Palmolive position peaked at $10.8K in Q2 2024.
  • 106 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.